Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop

By MarketWatch | Nov 21, 2024 at 02:00 AM EST

Stocks of anti-obesity drugmakers Eli Lilly, Novo Nordisk, and Amgen faced a downturn due to concerns about a potential impact of a Robert F. Kennedy Jr.-led Department of Health and Human Services. Despite worries, experts believe the selloff presents a buying opportunity.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.